Navigation Links
New Competitive Intelligence Speakers Spark Interest in Pharmaceutical Conference on October 1-2 in NJ
Date:9/19/2007

PARSIPPANY, N.J., Sept. 19 /PRNewswire/ -- Over 20 new speakers will grace the faculty of the "Pharma & Biotech Competitive Intelligence & Business Analysis" conference in two weeks in New Jersey. The conference is the gold standard for pharmaceutical CI, Business Analysis, and Market Forecasting executives; 200 from the top 25 companies will gather on October 1-2 to attend the meeting. Competition has never been fiercer to launch successful products and monitor competitor moves in crowded therapeutic classes. This year's show brings together an unprecedented gathering of speakers and attendees from around the industry.

Among the many new speakers the audience will have opportunity to hear from are:

-- Bill Sammon

Senior Director of Strategy Information Analysis

Pfizer

-- David Stefanoni

Director, Business Intelligence; Business Excellent, Analytics &

Planning

Sanofi-Aventis

-- David Kamenir

Associate Director, Strategic Brand & Competitor Insights

Novo Nordisk

-- Ian Malcolm

Vice President Strategic Marketing

Exelixis

-- Susanne Laningham

Director Business Analysis & Information

Amgen

-- Thomas Han

Director, Strategic Marketing

Biovail

-- J J Owen

Associate Director, Scientific & Competitor Analysis

Millennium

-- Joshua Owolabi

Assistant Director, Discovery & Assessment Group

TAP Pharmaceuticals

-- Renee Pierson

Director

Ortho McNeil Pharmaceutical

The conference and exhibition will take place in Parsippany, NJ and is the only annual conference featuring 90% pharmaceutical company speakers for just the life sciences industry, reports Mark Alexay of Apaporis, the organizer. 35 pharmaceutical company speakers are featured this year; the attendee list is posted at http://www.pharmabiotechci.com.

The speaking faculty includes a pharmaceutical industry "Who's Who" list of CI professionals from top companies including Alcon Laboratories, Amgen, Aspreva, Bayer HealthCare, Bayer Schering Pharma, Biovail, Boehringer Ingelheim, Centocor, Cyberonics, Cyclacel, Daiichi Medical Research, Eisai, Exelixis, Genentech, Genzyme, Merck, Millennium, Novo Nordisk, Onconova Therapeutics, Organon International, Ortho McNeil Pharmaceutical, Pfizer, Sanofi-Aventis, Shire Laboratories, Supernus Pharmaceuticals, TAP, Wyeth, ZymoGenetics.

Contact the organizers for information or about the exhibition -- Amy Yueh at ayueh@pharmabiotechci.com / 212.228.7974 or Mark Alexay at 201.452.4023.


'/>"/>
SOURCE Apaporis
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. In competitive biotech world, Wisconsin cant afford to fall behind
2. Modernizing the tax code can make Wisconsin tech businesses more competitive
3. Is Googles cafeteria a competitive weapon?
4. Wisconsin can shine in the competitive biotech world, even among the giants
5. Wisconsin must produce more science-savvy students to remain competitive
6. Is your competitive edge really a wedge?
7. Schneider Logistics Helps Manufacturers Secure Competitive Advantage
8. Looking to be Competitive? Try Speed Networking
9. Meat-snack maker selects Prescient Applied Intelligence tech package
10. Are you gathering information or intelligence about competitors?
11. Business Intelligence and Process Effectiveness Processes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 2017 In today,s pre-market research, ... the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate ... SYN), and Regulus Therapeutics Inc. (NASDAQ: RGLS ... Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn ... at: ...
(Date:3/22/2017)... Calif. , March 22, 2017  UBM ... proud to announce their extended partnership and the ... be headlined by the 21 st Annual ... Boston, taking place May 3-4, 2017. ... Medical Technology Association (ADVAMED) President and CEO, ...
(Date:3/22/2017)... , March 22, 2017 MarketNewsUpdates.com News ... ... conditions are being pressured as of late due to the ... pain management has a dramatic impact on patient,s quality of ... development activities for identifying new forms of opioid formulations that ...
(Date:3/22/2017)... ... March 21, 2017 , ... Okyanos Cell Therapy has announced ... of their live events series, “Stem Cell Therapy: The Next Phase in the Evolution ... 2013 Stem Cell Research and Therapy Act, Okyanos maintains a mission to ...
Breaking Biology Technology:
(Date:2/22/2017)... , Feb. 22, 2017 With ... 2021, ABI Research identifies four technologies that innovative ... to secure significant share in the changing competitive ... and passive authentication.   "Companies can ... comes to security," says Dimitrios Pavlakis , ...
(Date:2/14/2017)... , Feb. 14, 2017  Wake Forest Baptist Medical ... its new chief executive officer (CEO). Freischlag joins the ... John D. McConnell , M.D., who last year announced ... the Medical Center, after leading it since 2008.   ... scope of Wake Forest Baptist,s academic health system, which ...
(Date:2/9/2017)... LONDON , Feb. 9, 2017 The ... in-depth analysis of the biomass boiler market globally in ... sales of biomass boilers. The market for biomass boilers ... product type, end-user, application, and country/region. The market based ... agriculture & forest residues, biogas & energy crops, urban ...
Breaking Biology News(10 mins):